Patents by Inventor Kristine Svenson

Kristine Svenson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7630838
    Abstract: This invention is directed to the three dimensional crystal structure of Beta-site APP Cleaving Enzyme (BACE), and to the use of this structure in rational drug design methods to identify agents that may interact with active sites of BACE. Such agents may represent new therapeutics in the treatment and/or prevention of Alzheimer's Disease.
    Type: Grant
    Filed: September 19, 2001
    Date of Patent: December 8, 2009
    Assignee: American Home Products Corporation
    Inventors: Rajiv Chopra, Kristine Svenson, Bethany Annis Freeman, Tatos N. Akopian, Jonathan Bard, Mark Lloyd Stahl, William S. Somers
  • Publication number: 20070100560
    Abstract: This invention is directed to the crystal structures of MK2, and to the use of these structures in rational drug design methods to identify agents that may interact with active sites of MK2 proteins. Such agents may be useful as therapeutic agents.
    Type: Application
    Filed: December 6, 2006
    Publication date: May 3, 2007
    Inventors: Kevin Parris, Kathryn Underwood, Mark Stahl, Lidia Mosyak, Kristine Svenson, Tania Shane, Meggin Taylor
  • Patent number: 7167802
    Abstract: This invention is directed to the crystal structures of MK2, and to the use of these structures in rational drug design methods to identify agents that may interact with active sites of MK2 proteins. Such agents may be useful as therapeutic agents.
    Type: Grant
    Filed: November 13, 2002
    Date of Patent: January 23, 2007
    Assignee: Wyeth
    Inventors: Kevin D. Parris, Kathryn W. Underwood, Mark L. Stahl, Lidia Mosyak, Kristine Svenson, Tania Shane, Meggin L. Taylor
  • Publication number: 20040091872
    Abstract: This invention is directed to the crystal structures of MK2, and to the use of these structures in rational drug design methods to identify agents that may interact with active sites of MK2 proteins. Such agents may be useful as therapeutic agents.
    Type: Application
    Filed: November 13, 2002
    Publication date: May 13, 2004
    Inventors: Kevin D. Parris, Kathryn W. Underwood, Mark L. Stahl, Lidia Mosyak, Kristine Svenson, Tania Shane, Meggin L. Taylor
  • Publication number: 20020055459
    Abstract: This invention is directed to the three dimensional crystal structure of Beta-site APP Cleaving Enzyme (BACE), and to the use of this structure in rational drug design methods to identify agents that may interact with active sites of BACE. Such agents may represent new therapeutics in the treatment and/or prevention of Alzheimer's Disease.
    Type: Application
    Filed: September 19, 2001
    Publication date: May 9, 2002
    Inventors: Rajiv Chopra, Kristine Svenson, Bethany Annis, Tatos N. Akopian, Jonathan Bard, Mark Lloyd Stahl, William S. Somers